Loading…
Morphologic effects of estrogen stimulation on 3D MCF-7 microtissues
•Three-dimensional MCF-7 human breast carcinoma microtissue morphology is sensitive to disruption by estrogenic compounds.•Three-dimensional microtissue morphology changes are quantifiable and correspond to gene expression changes.•Selective activation of specific estrogen receptors alters microtiss...
Saved in:
Published in: | Toxicology letters 2016-04, Vol.248, p.1-8 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •Three-dimensional MCF-7 human breast carcinoma microtissue morphology is sensitive to disruption by estrogenic compounds.•Three-dimensional microtissue morphology changes are quantifiable and correspond to gene expression changes.•Selective activation of specific estrogen receptors alters microtissue morphology in a pathway-specific manner.
In the development of human cell-based assays, 3-dimensional (3D) cell culture models are intriguing as they are able to bridge the gap between animal models and traditional two-dimensional (2D) cell culture. Previous work has demonstrated that MCF-7 human breast carcinoma cells cultured in a 3D scaffold-free culture system self-assemble and develop into differentiated microtissues that possess a luminal space. Exposure to estradiol for 7 days decreased lumen formation in MCF-7 microtissues, altered microtissue morphology and altered expression of genes involved in estrogen signaling, cell adhesion and cell cycle regulation. Exposure to receptor-specific agonists for estrogen receptor alpha, estrogen receptor beta and g-protein coupled estrogen receptor resulted in unique, receptor-specific phenotypes and gene expression signatures. The use of a differentiated scaffold-free 3D culture system offers a unique opportunity to study the phenotypic and molecular changes associated with exposure to estrogenic compounds. |
---|---|
ISSN: | 0378-4274 1879-3169 |
DOI: | 10.1016/j.toxlet.2016.02.012 |